Problems of diagnosis and treatment of central serous chorioretinopathy in medical organizations of the Ministry of Defense

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The clinical characteristics of patients with central serous chorioretinopathy who were treated in the structures of the medical service of the Ministry of Defense of the Russian Federation were studied by analyzing the database of the S.M.Kirov Military Medical Academy. We performed a retrospective analysis of patients’ medical records for the period 2017-2019, who were examined using multimodal imaging, including fluorescence angiography and optical coherence tomography. In total, 79 patients with an average age of 44.8±10 years were selected for the study, of which 26 military personnel and 26 non - departmental patients were chosen for comparative analysis. It was determined that the disease’s initial severity, assessed by the subfoveal thickness of the choroid, was higher in the group of military personnel, which also had worse functional outcomes compared with unknown patients. Military personnel admitted for treatment from district hospitals have an increased incidence of glucocorticosteroid use as first - line treatment for central serous chorioretinopathy, resulting in part account for the greater severity and worse outcomes of the disease in this group.

Full Text

Restricted Access

About the authors

A. N Kulikov

The S.M.Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation

Email: alexey.kulikov@mail.ru
St. Petersburg, Russia

A. S Vasilev

The S.M.Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation

St. Petersburg, Russia

M. A Burnasheva

The S.M.Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation

St. Petersburg, Russia

D. S Maltsev

The S.M.Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation

St. Petersburg, Russia

References

  1. Мальцев Д.С., Куликов А.Н., Чхаблани Д., Кутик Д.С. Оптическая когерентная томография в диагностике и лечении центральной серозной хориоретинопатии // Вестн. офтальмол. - 2018. - Т. 134, № 6. - С. 15-24.
  2. Akkaya S. Spectrum of pachychoroid diseases // Int. Ophthalmol. - 2018. - Vol. 38, N 5. - P. 2239-2246.
  3. Daruich A., Matet A., Dirani A. et al. Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis // Prog. Retin. Eye. Res. - 2015. - Vol. 48. - P. 82-118.
  4. Eandi C.M., Ober M., Iranmanesh R. et al. Acute central serous chorioretinopathy and fundus autofluorescence // Retina. - 2005. - Vol. 25, N 8. - P. 989-993.
  5. Framme C., Walter A., Gabler B. et al. Fundus autofluorescence in acute and chronic-recurrent central serous chorioretinopathy // Acta Ophthalmol. Scand. - 2005. - Vol. 83, N 2. - P. 161-167.
  6. Gass J.D. Pathogenesis of disciform detachment of the neuroepithelium // Am. J. Ophthalmol. - 1967. - Vol. 63, N 3. - P. 1-139.
  7. Gupta P., Gupta V., Dogra M.R. et al. Morphological changes in the retinal pigment epithelium on spectral-domain OCT in the unaffected eyes with idiopathic central serous chorioretinopathy // Int. Ophthalmol. - 2010. - Vol. 30, N 2. - P. 175-181.
  8. Guyer D.R., Yannuzzi L.A., Slakter J.S. et al. Digital indocyanine green videoangiography of central serous chorioretinopathy // Arch. Ophthalmol. - 1994. - Vol. 112, N 8. - P. 1057-1062.
  9. Haimovici R., Koh S., Gagnon D.R. et al. Central serous chorioretinopathy case-control study group. Risk factors for central serous chorioretinopathy: a case-control study // Ophthalmology. - 2004. - Vol. 111, N 2. - P. 244-249.
  10. Imamura Y., Fujiwara T., Margolis R., Spaide R.F. Central serous chorioretinopathy and indocyanine green angiography // Retina. - 2009. - Vol. 29, N 10. - P. 1469-1473.
  11. Imamura Y., Fujiwara T., Margolis R., Spaide R.F. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy // Retina. - 2009. - Vol. 29. - P. 1469-1473.
  12. Imamura Y., Fujiwara T., Spaide R.F. Fundus autofluorescence and visual acuity in central serous chorioretinopathy // Ophthalmology. - 2011. - Vol. 118, N 4. - P. 700-705.
  13. Kim Y.Y., Flaxel C.J. Factors influencing the visual acuity of chronic central serous chorioretinopathy // Korean J. Ophthalmol. - 2011. - Vol. 25, N 2. - P. 90 -97.
  14. Liew G., Quin G., Gillies M., Fraser-Bell S. Central serous chorioretinopathy: a review of epidemiology and pathophysiology // Clin. Exp. Ophthalmol. - 2013. - Vol. 41, N 2. - P. 201-214.
  15. Liu B., Deng T., Zhang J. Risk factors for central serous chorioretinopathy: A Systematic Review and Meta-Analysis // Retina. - 2016. - Vol. 36, N 1. - P. 9-19.
  16. Maltsev D.S., Kulikov A.N., Chhablani J. Clinical Application of Fluorescein Angiography-Free Navigated Focal Laser Photocoagulation in Central Serous Chorioretinopathy // Ophthalmic Surg. Lasers Imaging Retina. - 2019. - Vol. 50, N 4. - P. e118-e124.
  17. Maltsev D.S., Kulikov A.N., Chhablani J. Topography-guided identification of leakage point in central serous chorioretinopathy: a base for fluorescein angiography-free focal laser photocoagulation // Br. J. Ophthalmol. - 2018. - Vol. 102, N 9. - P. 1218-1225.
  18. Manjunath V., Taha M., Fujimoto J.G., Duker J.S. Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography // Am. J. Ophthalmol. - 2010. - Vol. 150, N 3. - P. 325-329.
  19. Oh J.H, Oh J., Togloom A. et al. Biometric characteristics of eyes with central serous chorioretinopathy // Invest. Ophthalmol. Vis. Sci. - 2014. - Vol. 55, N 3. - P. 1502-1508.
  20. Perkin S.L., Kim J.E., Pollack J.S., Merrill P.T. Clinical characteristics of central serous chorioretinopathy in women // Ophthalmology. - 2002. - Vol. 109, N 2. - P. 262-266.
  21. Piccolino F.C., Borgia L. Central serous chorioretinopathy and indocyanine green angiography // Retina. - 1994. - Vol. 14, N 3. - P. 231-242.
  22. Spaide R.F., Klancnik J.M., Fundus autofluorescence and central serous chorioretinopathy // Ophthalmology. - 2005. - Vol. 112. - P. 825-833.
  23. Singh S.R, Matet A., van Dijk E.H.C. et al. Discrepancy in current central serous chorioretinopathy classification // Br. J. Ophthalmol. - 2019. - Vol. 103, N 6. - P. 737-742.
  24. Von Ruckmann A., Fitzke F.W., Fan J. et al. Abnormalities of fundus autofluorescence in central serous retinopathy // Am. J. Ophthalmol. - 2002. - Vol. 133, N 6. - P. 780-786.
  25. Wang M., Munch I.C., Hasler P.W. et al. Central serous chorioretinopathy // Acta Ophthalmol. - 2008. - Vol. 86, N 2. - P. 126-145.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2021 Kulikov A.N., Vasilev A.S., Burnasheva M.A., Maltsev D.S.



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: № 01975 от 30.12.1992.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies